Sort
326,823 grants matching “clinical trial”
GENE AND PHARMACOLOGICAL THERAPIES FOR CYSTIC FIBROSIS
$1,787,287Johns Hopkins University · P01 · FY2003 · HL
Pathophysiologic and therapeutic mechanisms of aspirin exacerbated respiratory d*
$1,787,094Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2012 · AI
CELLULAR BIOLOGY OF RENAL FUNCTION AND DISEASE
$1,787,088Dennis Brown · Massachusetts General Hospital · P01 · FY2011 · DK
Development of a nonhuman primate model of fetal Zika virus infection and disease
$1,786,954Koen K Van Rompay · University Of California At Davis · R21 · FY2017 · AI
Examining IL-15 and IL-7 as an immunotherapy agent in cancer and AIDS
$1,786,891Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
FOcal Cerebral Arteriopathy Steroids (FOCAS) Trial
$1,786,797Heather J Fullerton · University Of California, San Francisco · UH3 · FY2025 · NS
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,786,679Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2009 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,786,679Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Integrated Molecular Profiling of Diabetic Retinopathy
$1,786,652Vinit B Mahajan · Stanford University · R01 · FY2025 · EY
The role of post-natal skeletal stem cells in health and disease
$1,786,647Pamela G Robey · National Institute Of Dental & Craniofacial Research · ZIA · FY2009 · DE
Arkansas Center for Advancing Pediatric Therapeutics (ArCAPT)
$1,786,542Laura P James · Arkansas Children'S Hospital Res Inst · UG1 · FY2016 · OD
Strategies to Overcome Immune Resistance in Head and Neck Cancers
$1,786,322Sara Isabel Pai · Massachusetts General Hospital · P01 · FY2019 · CA
QUALITY ASSURANCE REVIEW CENTER (QARC)
$1,786,161Univ Of Massachusetts Med Sch Worcester · U10 · FY2004 · CA
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease
$1,786,110Jessica Alber · University Of Rhode Island · R01 · FY2024 · AG
ADULT AIDS CLINICAL TRIALS UNIT
$1,786,066Washington University · U01 · FY2001 · AI
Community-Based VCT: Zimbabwe
$1,785,937Stephen F Morin · University Of California, San Francisco · U01 · FY2009 · MH
COLORADO ADULT AIDS CLINICAL TRIALS UNIT
$1,785,928University Of Colorado Denver · U01 · FY2001 · AI
HIV Preventive Vaccine Studies
$1,785,677Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Development of Fludase as an Anti-Influenza Agent
$1,785,659Mang Yu · Nexbio, Inc. · U01 · FY2008 · AI
CureSC Manufacturing Resource Platform
$1,785,617Angelo A. Cardoso · Beckman Research Institute/City Of Hope · OT3 · FY2023 · HL
Comparative Modeling: Informing Breast Cancer Control Practice and Policy
$1,785,514Jeanne Mandelblatt · Georgetown University · U01 · FY2016 · CA
Point of Care Center for Emerging Neurotechnologies (POC-CENT)
$1,785,379Fred Richard Beyette · University Of Cincinnati · U54 · FY2011 · EB
Pathogenesis and Treatment of HIV Infection
$1,785,365H. Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
$1,785,237Josh F. Peterson · Vanderbilt University Medical Center · U01 · FY2019 · HG
NIAID CLINICAL RESEARCH AUDITING
$1,785,068Jan Peterson · The Emmes Company, Llc · N01 · FY2012 · AI